ReviewInternational journal of clinical and experimental pathology2025

Evaluation of the efficacy and safety of durvalumab combined with chemotherapy, radiotherapy, or other agents in advanced non-small cell lung cancer: a meta-analysis.

Min Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.